Journal article icon

Journal article

New Therapeutics in Alzheimer’s Disease longitudinal cohort study (NTAD): study protocol

Abstract:

Introduction With the pressing need to develop treatments that slow or stop the progression of Alzheimer’s disease, new tools are needed to reduce clinical trial duration and validate new targets for human therapeutics. Such tools could be derived from neurophysiological measurements of disease.

Methods and analysis The New Therapeutics in Alzheimer’s Disease study (NTAD) aims to identify a biomarker set from magneto/electroencephalography that is...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/bmjopen-2021-055135

Authors


More by this author
Role:
Author
ORCID:
0000-0002-6626-7686
More by this author
Role:
Author
ORCID:
0000-0002-6292-7472
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author
ORCID:
0000-0003-2267-9897
More from this funder
Name:
Wellcome Trust
Grant:
104571/Z/14/Z
Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
12
Article number:
e055135
Publication date:
2022-12-15
Acceptance date:
2022-11-01
DOI:
EISSN:
2044-6055
Language:
English
Keywords:
Pubs id:
1315378
Local pid:
pubs:1315378
Deposit date:
2022-12-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP